Nyd den ubegrænsede adgang til tusindvis af spændende e- og lydbøger - helt gratis
Frontiers in Cardiovascular Drug Discovery is a book series devoted to publishing the latest advances in cardiovascular drug design and discovery. Each volume brings reviews on the biochemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, recent important patents, and structure-activity relationships of molecules used in cardiovascular therapy. The book series should prove to be of great interest to all medicinal chemists and pharmaceutical scientists involved in preclinical and clinical research in cardiology.
The fifth volume of the series covers the following topics:
-The Lipid Hypothesis: From Resins to Proprotein Convertase Subtilisin/Kexin Type-9 Inhibitors -The Role of SGLT2i in the Prevention and Treatment of Heart Failure -Natural Products and Semi-Synthetic Compounds as Antithrombotics: A Review of the Last Ten Years (2009-2019) -Transient Receptor Potential Channels: Therapeutic Targets for Cardiometabolic Diseases? -Treatment of Raynaud’s Phenomenon -Traditional Medicine Based Cardiovascular Therapeutics -Cardiovascular Disease: A Systems Biology Approach
© 2020 Bentham Science (E-bog): 9789811413247
Release date
E-bog: 3. oktober 2020
Over 600.000 titler
Download og nyd titler offline
Eksklusive titler + Mofibo Originals
Børnevenligt miljø (Kids Mode)
Det er nemt at opsige når som helst
For dig som lytter og læser ofte.
1 konto
100 timer/måned
Eksklusivt indhold hver uge
Fri lytning til podcasts
Ingen binding
For dig som lytter og læser ubegrænset.
1 konto
Ubegrænset adgang
Eksklusivt indhold hver uge
Fri lytning til podcasts
Ingen binding
For dig som ønsker at dele historier med familien.
2-6 konti
100 timer/måned pr. konto
Fri lytning til podcasts
Kun 39 kr. pr. ekstra konto
Ingen binding
2 konti
179 kr. /månedFor dig som vil prøve Mofibo.
1 konto
20 timer/måned
Eksklusivt indhold hver uge
Fri lytning til podcasts
Gem ubrugt tid
Ingen binding
Dansk
Danmark